{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T15:53:57Z","timestamp":1793116437431,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Science Foundation of China","award":["82260555"],"award-info":[{"award-number":["82260555"]}]},{"name":"The Gansu Provincial Science and Technology Major Project","award":["22ZD6FA021-4"],"award-info":[{"award-number":["22ZD6FA021-4"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01847-0","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T17:39:07Z","timestamp":1756402747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Elevated expression of transferrin receptor-1 in pancreatic cancer: clinical implications and prognostic significance"],"prefix":"10.1007","volume":"25","author":[{"given":"Li","family":"Zhongqing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Wence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"issue":"1","key":"1847_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/op.22.00328","volume":"19","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Sohal DPS. Pancreatic adenocarcinoma management. JCO Oncol Pract. 2023;19(1):19\u201332. https:\/\/doi.org\/10.1200\/op.22.00328.","journal-title":"JCO Oncol Pract"},{"issue":"11","key":"1847_CR2","doi-asserted-by":"publisher","first-page":"e2443198","DOI":"10.1001\/jamanetworkopen.2024.43198","volume":"7","author":"HM Bizuayehu","year":"2024","unstructured":"Bizuayehu HM, et al. Global disparities of cancer and its projected burden in 2050. JAMA Netw Open. 2024;7(11):e2443198. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.43198.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"1847_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.4251\/wjgo.v15.i4.571","volume":"15","author":"YT Fang","year":"2023","unstructured":"Fang YT, et al. Recent advances in targeted therapy for pancreatic adenocarcinoma. World J Gastrointest Oncol. 2023;15(4):571\u201395. https:\/\/doi.org\/10.4251\/wjgo.v15.i4.571.","journal-title":"World J Gastrointest Oncol"},{"issue":"1","key":"1847_CR4","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10555-020-09948-w","volume":"40","author":"B Al-Share","year":"2021","unstructured":"Al-Share B, Hammad N, Diab M. Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy. Cancer Metastasis Rev. 2021;40(1):355\u201371. https:\/\/doi.org\/10.1007\/s10555-020-09948-w.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"1847_CR5","doi-asserted-by":"publisher","DOI":"10.4081\/oncol.2019.410","volume":"13","author":"S Hasan","year":"2019","unstructured":"Hasan S, et al. Advances in pancreatic cancer biomarkers. Oncol Rev. 2019;13(1): 410. https:\/\/doi.org\/10.4081\/oncol.2019.410.","journal-title":"Oncol Rev"},{"issue":"1","key":"1847_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02640-9","volume":"22","author":"H Wu","year":"2022","unstructured":"Wu H, et al. Advances in biomarkers and techniques for pancreatic cancer diagnosis. Cancer Cell Int. 2022;22(1): 220. https:\/\/doi.org\/10.1186\/s12935-022-02640-9.","journal-title":"Cancer Cell Int"},{"key":"1847_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.607692","volume":"12","author":"PV Candelaria","year":"2021","unstructured":"Candelaria PV, et al. Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents. Front Immunol. 2021;12: 607692. https:\/\/doi.org\/10.3389\/fimmu.2021.607692.","journal-title":"Front Immunol"},{"key":"1847_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.freeradbiomed.2018.06.037","volume":"133","author":"H Kawabata","year":"2019","unstructured":"Kawabata H. Transferrin and transferrin receptors update. Free Radic Biol Med. 2019;133:46\u201354. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.06.037.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1847_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03275-8","volume":"24","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. LASS2 suppresses metastasis in multiple cancers by regulating the ferroptosis signalling pathway through interaction with TFRC. Cancer Cell Int. 2024;24(1): 87. https:\/\/doi.org\/10.1186\/s12935-024-03275-8.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"1847_CR10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.7150\/ijbs.80737","volume":"19","author":"J Shan","year":"2023","unstructured":"Shan J, et al. NUF2 drives cholangiocarcinoma progression and migration via inhibiting autophagic degradation of TFR1. Int J Biol Sci. 2023;19(5):1336\u201351. https:\/\/doi.org\/10.7150\/ijbs.80737.","journal-title":"Int J Biol Sci"},{"key":"1847_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081715","author":"R Villalobos-Manzo","year":"2022","unstructured":"Villalobos-Manzo R, et al. Identification of transferrin receptor 1 (TfR1) overexpressed in lung cancer cells, and internalization of magnetic Au-CoFe(2)O(4) core-shell nanoparticles functionalized with its ligand in a cellular model of small cell lung cancer (SCLC). Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14081715.","journal-title":"Pharmaceutics"},{"key":"1847_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.756895","volume":"9","author":"C Yang","year":"2022","unstructured":"Yang C, et al. Role of TFRC as a novel prognostic biomarker and in immunotherapy for pancreatic carcinoma. Front Mol Biosci. 2022;9: 756895. https:\/\/doi.org\/10.3389\/fmolb.2022.756895.","journal-title":"Front Mol Biosci"},{"key":"1847_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2019.1670063","author":"N Kamyabi","year":"2019","unstructured":"Kamyabi N, Bernard V, Maitra A. Liquid biopsies in pancreatic cancer. Expert Rev Anticancer Ther. 2019. https:\/\/doi.org\/10.1080\/14737140.2019.1670063.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"1847_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10(1): 165. https:\/\/doi.org\/10.1186\/s40537-023-00844-y.","journal-title":"J Big Data"},{"issue":"7","key":"1847_CR15","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.2174\/1386207326666230810142646","volume":"27","author":"B Zhong","year":"2024","unstructured":"Zhong B, et al. Clinicopathological characteristics, prognosis, and correlated tumor cell function of Tropomodulin-3 in pancreatic adenocarcinoma. Comb Chem High Throughput Screen. 2024;27(7):1011\u201321. https:\/\/doi.org\/10.2174\/1386207326666230810142646.","journal-title":"Comb Chem High Throughput Screen"},{"key":"1847_CR16","unstructured":"Commission, G.O.o.N.H., Standard for diagnosis and treatment of pancreatic cancer (2022 edition) .Journal of clinical hepatology. 2022. 38(05): p. 1006\u20131015.DOI:10.3969\/j.issn.1001-5256.2022.05.007"},{"issue":"1","key":"1847_CR17","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2022.2129884","volume":"36","author":"HM Kolbeinsson","year":"2023","unstructured":"Kolbeinsson HM, et al. Pancreatic cancer: a review of current treatment and novel therapies. J Invest Surg. 2023;36(1): 2129884. https:\/\/doi.org\/10.1080\/08941939.2022.2129884.","journal-title":"J Invest Surg"},{"issue":"1","key":"1847_CR18","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM. Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2024;21(1):7\u201324. https:\/\/doi.org\/10.1038\/s41575-023-00840-w.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"21","key":"1847_CR19","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1158\/1078-0432.Ccr-21-3452","volume":"28","author":"B Bockorny","year":"2022","unstructured":"Bockorny B, Grossman JE, Hidalgo M. Facts and hopes in immunotherapy of pancreatic cancer. Clin Cancer Res. 2022;28(21):4606\u201317. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-21-3452.","journal-title":"Clin Cancer Res"},{"key":"1847_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713340","author":"AA Seyhan","year":"2023","unstructured":"Seyhan AA. Circulating micrornas as potential biomarkers in pancreatic cancer-advances and challenges. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713340.","journal-title":"Int J Mol Sci"},{"key":"1847_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14122574","author":"T Kaur","year":"2022","unstructured":"Kaur T, et al. Investigation of trends in the research on transferrin receptor-mediated drug delivery via a bibliometric and thematic analysis. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14122574.","journal-title":"Pharmaceutics"},{"key":"1847_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4257342","author":"J Cao","year":"2022","unstructured":"Cao J, et al. Aberrant expression TFR1\/CD71 in gastric cancer identifies a novel potential prognostic marker and therapeutic target. Evid Based Compl Alternat Med. 2022. https:\/\/doi.org\/10.1155\/2022\/4257342.","journal-title":"Evid Based Compl Alternat Med"},{"key":"1847_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2021.104246","volume":"243","author":"M Tang","year":"2021","unstructured":"Tang M, et al. Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening. J Proteomics. 2021;243: 104246. https:\/\/doi.org\/10.1016\/j.jprot.2021.104246.","journal-title":"J Proteomics"},{"issue":"17","key":"1847_CR24","doi-asserted-by":"publisher","first-page":"21671","DOI":"10.18632\/aging.203512","volume":"13","author":"F Chen","year":"2021","unstructured":"Chen F, et al. Integrated analysis identifies Tfr1 as a prognostic biomarker which correlates with immune infiltration in breast cancer. Aging. 2021;13(17):21671\u201399. https:\/\/doi.org\/10.18632\/aging.203512.","journal-title":"Aging"},{"key":"1847_CR25","doi-asserted-by":"publisher","first-page":"134777","DOI":"10.1016\/j.ijbiomac.2024.134777","volume":"278","author":"MD Caverzan","year":"2024","unstructured":"Caverzan MD, Ibarra LE. Advancing glioblastoma treatment through iron metabolism: A focus on TfR1 and Ferroptosis innovations. Int J Biol Macromol. 2024;278:134777. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.134777.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"1847_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/ajcn\/nqab217","volume":"114","author":"S Juli\u00e1n-Serrano","year":"2021","unstructured":"Juli\u00e1n-Serrano S, et al. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Am J Clin Nutr. 2021;114(4):1408\u201317. https:\/\/doi.org\/10.1093\/ajcn\/nqab217.","journal-title":"Am J Clin Nutr"},{"issue":"27","key":"1847_CR27","doi-asserted-by":"publisher","first-page":"10760","DOI":"10.1021\/jacs.9b03720","volume":"141","author":"X Wu","year":"2019","unstructured":"Wu X, et al. Elucidation and structural modeling of CD71 as a molecular target for cell-specific aptamer binding. J Am Chem Soc. 2019;141(27):10760\u20139. https:\/\/doi.org\/10.1021\/jacs.9b03720.","journal-title":"J Am Chem Soc"},{"issue":"4","key":"1847_CR28","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1002\/ptr.6971","volume":"35","author":"H Yang","year":"2021","unstructured":"Yang H, et al. Chlorogenic acid depresses cellular bioenergetics to suppress pancreatic carcinoma through modulating c-Myc-TFR1 axis. Phytother Res. 2021;35(4):2200\u201310. https:\/\/doi.org\/10.1002\/ptr.6971.","journal-title":"Phytother Res"},{"key":"1847_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113736","volume":"155","author":"T Brogy\u00e1nyi","year":"2022","unstructured":"Brogy\u00e1nyi T, et al. Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells. Biomed Pharmacother. 2022;155: 113736. https:\/\/doi.org\/10.1016\/j.biopha.2022.113736.","journal-title":"Biomed Pharmacother"},{"key":"1847_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/biom14080947","author":"C Garc\u00eda-Montero","year":"2024","unstructured":"Garc\u00eda-Montero C, et al. Abnormal histopathological expression of Klotho, ferroptosis, and circadian clock regulators in pancreatic ductal adenocarcinoma: prognostic implications and correlation analyses. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14080947.","journal-title":"Biomolecules"},{"issue":"10","key":"1847_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.trecan.2021.04.005","volume":"7","author":"X Chen","year":"2021","unstructured":"Chen X, et al. Targeting ferroptosis in pancreatic cancer: a double-edged sword. Trends Cancer. 2021;7(10):891\u2013901. https:\/\/doi.org\/10.1016\/j.trecan.2021.04.005.","journal-title":"Trends Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01847-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01847-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01847-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:49:41Z","timestamp":1764917381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01847-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1847"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01847-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All authors give their consent for publication of the manuscript if accepted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"307"}}